News
Press Releases
May 13, 2026
Stellaromics® Appoints Veronica Mankinen as SVP Global Commercial Operations and John Leamon as SVP Product Development
February 19, 2026
Stellaromics Launches Pyxa™ at AGBT, the First Commercial Platform for 3D Spatial Multi-Omics in Intact Tissue
February 10, 2026
Stellaromics Appoints Industry Veterans Stacie Weninger and Steve McPhail to Board of Directors
January 28, 2026
Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine
December 3, 2025
Stellaromics Establishes First U.S. Pyxa™ 3D Spatial Transcriptomics Site at UC Irvine
October 14, 2025
Stellaromics Announces Installation of First Pyxa™ 3D Spatial Transcriptomics System at the University of Glasgow
April 24, 2025
Stellaromics Announces First Deployment of Pyxa Platform in Europe
February 11, 2025
Stellaromics Secures Significant Funding to Advance 3D Spatial Biology
November 2, 2023
Stellaromics Secures $25 Million in Series A Funding to Advance 3D Spatial Multi-omic Profiling
Media Coverage
May 12, 2026
Why Cancer Breakthroughs Alone Aren’t Enough
May 5, 2026
Driving Precision Oncology Through Data and Collaboration
March 24, 2026
Mapping Disease Through Advances in Spatial Phenotyping
March 6, 2026
Genomics, multiomics, and spatial biology at AGBT 2026
March 4, 2026
AGBT: Spatial Biology Field ‘Maturing’ as Updates Well-Received, if Not Flashy
March 10, 2026
AGBT 2026: What’s Next for Spatial Biology
February 25, 2026
Omics in Orlando: A Video Report from AGBT, Day One
February 19, 2026
Inside AGBT: Big Announcements and Bigger Implications
February 17, 2026
Bringing Tissue Biology Into 3D: Redefining What’s Possible in Spatial Multiomics
January 30, 2026
2026 MedTech M&A Surge, Nona’s Immunology Push, Stellaromics’ Brain Research, and AI in Biotech
November 10, 2025
Stellar Spatial Biology with 3D Multiomics
October 18, 2025
October 8, 2025
Exploring Biology in Three Dimensions
October 7, 2025
Introducing BioSpace’s 2025 40 Under 40 Winners
September 5, 2025
Ye Fu: Co-Founder and Chief Scientific Officer
August 12, 2025
Single Cell Analysis: A New Dimension of Discovery
July 29. 2025
Advances in Spatial Immune Profiling
July 1, 2025
A New Dimension for Drug Discovery
April 17, 2025
Stellaromics Dives into the Thick of Spatial Genomics
April 1, 2025
March 17, 2025
New Genomics Tools and Methods Shared at AGBT 2025
February 28, 2025
Highlights from AGBT 2025 – Part II
Stellaromics 3D Spatial Platform Sees Early-Access Interest From Cancer Researcher
February 27, 2025
Landscape of Sequencing-based Spatial RNA Technology
The Sun Sets on AGBT 2025: Final Report from Marco Island